Kappa-opioid receptor modulation of nicotine-induced behaviour (Q44333473)

2 December 2017

title

Kappa-opioid receptor modulation of nicotine-induced behaviour (English)

1 reference

2 December 2017

0 references

B Hahn

1

1 reference

2 December 2017

I P Stolerman

series ordinal

2

1 reference

2 December 2017

M Shoaib

series ordinal

3

1 reference

2 December 2017

publication date

1 October 2000

1 reference

2 December 2017

1 reference

2 December 2017

volume

39

1 reference

2 December 2017

issue

13

1 reference

2 December 2017

page(s)

2848-2855

1 reference

Dynorphin Is a Specific Endogenous Ligand of the κ Opioid Receptor

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900119-2

The effects of nicotine on locomotor activity in non-tolerant and tolerant rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900119-2

The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900119-2

The effects of the kappa agonist U-50,488 on cocaine-induced conditioned and unconditioned behaviors and Fos immunoreactivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900119-2

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900119-2

Blockade of morphine reward through the activation of kappa-opioid receptors in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900119-2

Kappa opioid inhibition of morphine and cocaine self-administration in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900119-2

The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900119-2

CI-977, a novel and selective agonist for the kappa-opioid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900119-2

Long term kappa-opioid receptor blockade following nor-binaltorphimine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900119-2

Effect of ventral tegmental 6-hydroxydopamine lesions on the locomotor stimulant action of nicotine in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900119-2

(+/-)Cyclazocine blocks the dopamine response to nicotine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900119-2

U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900119-2

Interactions between mu and kappa opioid agonists in the rat drug discrimination procedure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900119-2

Infusion of nicotine in the ventral tegmental area or the nucleus accumbens of the rat differentially affects accumbal dopamine release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900119-2

Inhibition of the neuronal nicotinic receptor-mediated current by kappa opioid receptor agonists in PC12 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900119-2

Locomotor activity in rats after administration of nicotinic agonists intracerebrally

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900119-2

Involvement of mesolimbic kappa-opioid systems in the discriminative stimulus effects of morphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900119-2

The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900119-2

Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900119-2

Evidence that nor-binaltorphimine can function as an antagonist at multiple opioid receptor subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900119-2

Comparative effects of selective kappa-opioid receptor agonists on dopamine levels in the dorsal caudate of freely moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900119-2

10.1016/S0028-3908(00)00119-2

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference